LSV ASSET MANAGEMENT - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 55 filers reported holding PSYCHEMEDICS CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LSV ASSET MANAGEMENT ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q4 2018$531,000
-31.6%
33,508
-18.8%
0.00%0.0%
Q3 2018$776,000
-9.7%
41,287
-7.6%
0.00%0.0%
Q2 2018$859,000
-7.0%
44,6880.0%0.00%0.0%
Q1 2018$924,000
-0.8%
44,688
-1.3%
0.00%0.0%
Q4 2017$931,000
+64.8%
45,288
+47.6%
0.00%0.0%
Q3 2017$565,000
-14.1%
30,688
+16.2%
0.00%0.0%
Q2 2017$658,000
+265.6%
26,404
+193.4%
0.00%
Q1 2017$180,0009,0000.00%
Other shareholders
PSYCHEMEDICS CORP shareholders Q3 2018
NameSharesValueWeighting ↓
Tieton Capital Management, LLC 295,630$5,064,0003.16%
KELLEHER FINANCIAL ADVISORS 141,525$2,424,0001.32%
NAPLES GLOBAL ADVISORS, LLC 59,070$1,012,0000.62%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 164,106$2,811,0000.38%
North Star Investment Management Corp. 95,950$1,644,0000.34%
RBF Capital, LLC 78,495$1,345,0000.33%
New Jersey Better Educational Savings Trust 11,000$188,0000.09%
KENNEDY CAPITAL MANAGEMENT LLC 275,428$4,718,0000.09%
Hillsdale Investment Management Inc. 14,530$249,0000.07%
Granite Investment Partners, LLC 25,775$442,0000.07%
View complete list of PSYCHEMEDICS CORP shareholders